Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132949) titled 'A Clinical Study of Maintenance Chemotherapy Regimens After Resectable Pancreatic Cancer: A Multi-center, Prospective, Randomized Controlled Trial' on Sept. 20.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Fujian Medical University Union Hospital
Condition:
pancreatic cancer
Intervention:
Capecitabine maintenance group:Oral capecitabine monotherapy for maintenance chemotherapy
S-1 maintenance group:Oral S-1 monotherapy for maintenance chemotherapy
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-21
Target Sample Size: Capecitabine maintenan...